Monia Lenzi

Dr. Monia Lenzi

Department of Pharmacy and Biotechnology, Alma Mater Studiorum University of Bologna, Bologna, Italy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
ACAlberto Chiarini
Alberto Chiarini
MATTEO MICUCCIMATTEO MICUCCI
MATTEO MICUCCI
Marco MalagutiMarco Malaguti
Marco Malaguti
Roberta BudriesiRoberta Budriesi
Roberta Budriesi
PIPierfranco Ioan
Pierfranco Ioan
SHSilvana Hrelia
Silvana Hrelia
This work was aimed at evaluating the cardioprotective effects ofCastanea sativaMill. (CSM) bark extract characterized in its phenolic composition by HPLC-DAD-MS analysis. The study was performed using primary cultures of neonatal rat cardiomyocytes to investigate the antioxidant and cytoprotective effects of CSM bark extract and isolated guinea pig left and right atria, left papillary muscle, and aorta to evaluate its direct effect on cholinergic and adrenergic response. In cultured cardiomyocytes the CSM bark extract reduced intracellular reactive oxygen species formation and improved cell viability following oxidative stress in dose-dependent manner. Moreover, the extract decreased the contraction induced by noradrenaline (1 μM) in guinea pig aortic strips and induced transient negative chronotropic and positive inotropic effects without involvement of cholinergic or adrenergic receptors in the guinea pig atria. Our results indicate that CSM bark extract exhibits antioxidant activity and might induce cardioprotective effect.

12 November 2018 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
MLMonia Lenzi
Monia Lenzi
VCVeronica Cocchi
Veronica Cocchi
ANAleksandra Novaković
Aleksandra Novaković
Maja KaramanMaja Karaman
Maja Karaman
MSMarijana Božidar Sakač
Marijana Božidar Sakač
Silvana HreliaSilvana Hrelia
Silvana Hrelia
The interest towards botanicals and plant extracts has strongly risen due to their numerous biological effects and ability to counteract chronic diseases development. Among these effects, chemoprevention which represents the possibility to counteract the cancerogenetic process is one of the most studied. The extracts of mushroom Meripilus giganteus (MG) (Phylum of Basidiomycota) showed to exert antimicrobic, antioxidant and antiproliferative effects. Therefore, since its effect in leukemic cell lines has not been previously evaluated, we studied its potential chemopreventive effect in Jurkat and HL-60 cell lines. MG ethanolic extract was characterized for its antioxidant activity and scavenging effect against different radical species. Moreover, its phenolic profile was evaluated by HPLC-MS-MS analyses. Flow cytometry (FCM) analyses of Jurkat and HL-60 cells treated with MG extract (0–750 μg/mL) for 24–72 h- allowed to evaluate its cytotoxicity, pro-apoptotic and anti-proliferative effect. To better characterize MG pro-apoptotic mechanism ROS intracellular level and the gene expression level of FAS, BAX and BCL2 were also evaluated. Moreover, to assess MG extract selectivity towards cancer cells, its cytotoxicity was also evaluated in human peripheral blood lymphocytes (PBL). MG extract induced apoptosis in Jurkat and HL-60 cells in a dose- and time- dependent manner by increasing BAX/BCL2 ratio, reducing ROS intracellular level and inducing FAS gene expression level. In fact, reduced ROS level is known to be related to the activation of apoptosis in leukemic cells by the involvement of death receptors. MG extract also induced cell-cycle arrest in HL-60 cells. Moreover, IC50 at 24 h treatment resulted 2 times higher in PBL than in leukemic cell lines. Our data suggest that MG extract might be considered a promising and partially selective chemopreventive agent since it is able to modulate different mechanisms in transformed cells at concentrations lower than in non-transformed ones.

Verified
Journal Article
Open access
PDF file
VCVeronica Cocchi
Veronica Cocchi
SGSofia Gasperini
Sofia Gasperini
Patrizia HRELIAPatrizia HRELIA
Patrizia HRELIA
Micaela TirriMicaela Tirri
Micaela Tirri
Matteo MartiMatteo Marti
Matteo Marti
MLMonia Lenzi
Monia Lenzi
Psychedelic and stimulating phenethylamines belong to the family of new psychoactive substances (NPS). The acute toxicity framework has begun to be investigated, while studies showing genotoxic potential are very limited or not available. Therefore, in order to fill this gap, the aim of the present work was to evaluate the genotoxicity by treating TK6 cells with 2C-H, 2C-I, 2C-B, 25B-NBOMe, and the popular 3,4-Methylenedioxymethylamphetamine (MDMA). On the basis of cytotoxicity and cytostasis results, we selected the concentrations (6.25–35 µM) to be used in genotoxicity analysis. We used the micronucleus (MN) as indicator of genetic damage and analyzed the MNi frequency fold increase by an automated flow cytometric protocol. All substances, except MDMA, resulted genotoxic; therefore, we evaluated reactive oxygen species (ROS) induction as a possible mechanism at the basis of the demonstrated genotoxicity. The obtained results showed a statistically significant increase in ROS levels for all genotoxic phenethylamines confirming this hypothesis. Our results highlight the importance of genotoxicity evaluation for a complete assessment of the risk associated also with NPS exposure. Indeed, the subjects who do not have hazardous behaviors or require hospitalization by using active but still “safe” doses could run into genotoxicity and in the well-known long-term effects associated.

16 May 2019 in GeroScience
Verified
Journal Article
Closed access
PDF file
AAAmany Attaallah
Amany Attaallah
MLMonia Lenzi
Monia Lenzi
SMSilvia Marchionni
Silvia Marchionni
GBGiacomo Bincoletto
Giacomo Bincoletto
VCVeronica Cocchi
Veronica Cocchi
Antonello LorenziniAntonello Lorenzini
Antonello Lorenzini

20 April 2020 in Plasma Processes and Polymers
Verified
Journal Article
Closed access
PDF file
Eleonora TurriniEleonora Turrini
Eleonora Turrini
RLRomolo Laurita
Romolo Laurita
ESEmanuele Simoncelli
Emanuele Simoncelli
Augusto StancampianoAugusto Stancampiano
Augusto Stancampiano
ECElena Catanzaro
Elena Catanzaro
Carmela FimognariCarmela Fimognari
Carmela Fimognari

4 December 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
MLMonia Lenzi
Monia Lenzi
VCVeronica Cocchi
Veronica Cocchi
MMMarco Malaguti
Marco Malaguti
MBMaria Cristina Barbalace
Maria Cristina Barbalace
SMSilvia Marchionni
Silvia Marchionni
Patrizia HRELIAPatrizia HRELIA
Patrizia HRELIA
6-(Methylsulfonyl) hexyl isothiocyanate as potential chemopreventive agent: molecular and cellular profile in leukaemia cell lines 6-(Methylsulfonyl) hexyl isothiocyanate as potential chemopreventive agent: molecular and cellular profile in leukaemia cell lines